J and J Snack Foods Newswire

Comprehensive Real-Time News Feed for J and J Snack Foods.

Results 1 - 20 of 590 in J and J Snack Foods

  1. Here Come Generics - Test Strips and a New All-In-One MeterRead the original story

    Thursday Apr 17 | Diabetes Mine

    It almost seems that a new era of alternative test strips and other "basic" diabetes products has hit.

    Comment?

  2. Billionaire Ken Fisher's Top Stock PicksRead the original story

    22 hrs ago | The Motley Fool

    Money managers must disclose their stock holdings every quarter, giving investors like you and me a peek into their portfolios.

    Comment?

  3. MarketResearchReports.Com: Global Ulcerative Colitis Market: Simponi...Read the original story

    Yesterday | SBWire

    The global ulcerative colitis market value will increase steadily over the coming years, growing from almost $4.2 billion in 2012 to approximately $6.6 billion by 2022, at a Compound Annual Growth Rate of 4.7%, according to a new report from research and consulting firm by Publisher.

    Comment?

  4. Maybe It's Time to Think About This Multibillion-Dollar Food CompanyRead the original story

    Monday | GuruFocus.com

    General Mills Inc. has a distinguished portfolio of leading brands. The company manufactures its products in 16 countries and sells them in more than 100 countries.

    Comment?

  5. Easter Sprintcar Trail victory caps career-best summer for VealRead the original story

    Monday | Warrnambool Standard

    A SEASON which he could only dream of has finished with yet another breakthrough win for Warrnambool sprintcar driver Jamie Veal.

    Comment?

  6. China Biotech In Review: Unnamed Entity Raises Chindex Bid To $23Read the original story

    Sunday Apr 20 | Seeking Alpha

    Chindex , the US-based operator of China hospitals and clinics, received a new takeover offer of $23 per share from an undisclosed entity .

    Comment?

  7. Why Medtronic Is One of the Smartest Companies on the PlanetRead the original story w/Photo

    Saturday Apr 19 | The Motley Fool

    The report cited Medtronic's 2 gram pacemaker, the tiniest in the world, as its top example.

    Comment?

  8. Johnson & Johnson's 3 Major StrengthsRead the original story

    Thursday Apr 17 | The Motley Fool

    Now seems like an opportune moment to check out the strengths of J&J as a group, with this article being the first of four that, in turn, will highlight the strengths, weaknesses, opportunities, and threats it is facing.

    Comment?

  9. J&J Q1 net up 8 percent on sales jump, lower costsRead the original story w/Photo

    Tuesday Apr 15 | Deseret News

    This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla.

    Comment?

  10. U.S. stocks rise, extending gains into third dayRead the original story w/Photo

    Wednesday Apr 16 | The Times

    Magic turnaround on Wall Street: Summary: Stocks beat back declines to finish higher in another choppy session with help from Coke, J&J earnings; Yahoo beats after the bell, but Intel results mixed; Twitter flies against troubled time for tech.

    Comment?

  11. J&J stock soars after big profit gainRead the original story

    Wednesday Apr 16 | Hispanic Business

    It helped J&J exceed the predictions of , the company has been trying to regain its position as one of corporate America's most admired companies.

    Comment?

  12. J&J's Q1 profit up 8% on sales jump, lower costsRead the original story

    Wednesday Apr 16 | Modern Healthcare

    A turnaround in Johnson & Johnson's prescription medicine business fueled by new drugs , combined with reduced production and administration expenses, lifted first-quarter profit by 8%.

    Comment?

  13. J&J beats forecasts as sales of new drugs shineRead the original story

    Wednesday Apr 16 | Lincoln Daily News

    J ohnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view.

    Comment?

  14. Ethicon develops the suture of the future at a 80 million Limerick plantRead the original story w/Photo

    Wednesday Apr 16 | Limerick Today

    A SENIOR executive with Johnson & Johnson has said the local pool of talent and the multinational's positive experience of Limerick were crucial in selecting the city for an Dan Wildman, worldwide president of Ethicon Biosurgery, a J&J company, said that the ... (more)

    Comment?

  15. India Morning Call-Global MarketsRead the original story

    Tuesday Apr 15 | Reuters

    U.S. stocks ended a volatile session higher on Tuesday, lifted by gains in such blue-chip names as Coca-Cola and Johnson & Johnson, though persistent weakness in momentum names limited the Nasdaq's advance.

    Comment?

  16. Magic turnaround on Wall StreetRead the original story

    Tuesday Apr 15 | Reuters

    Up arrows just don't tell the whole story on a day where the Dow bounced between a hundred-point win and a hundred-point loss.

    Comment?

  17. J&J Q1 net up 8 percent on sales jump, lower costsRead the original story w/Photo

    Tuesday Apr 15 | The Miami Herald

    This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla.

    Comment?

  18. J and J net up 8%Read the original story

    Tuesday Apr 15 | Worcester Telegram & Gazette

    Johnson & Johnson's first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales.

    Comment?

  19. J&J Pharmaceutical Success Drives Increase in 2014 ForecastRead the original story

    Tuesday Apr 15 | The Washington Post

    Johnson & Johnson, the world's biggest maker of health-care products, beat expectations and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices.

    Comment?

  20. Global Markets-Ukraine worries weigh on global shares, drive up bondsRead the original story

    Tuesday Apr 15 | Reuters

    Global equity markets traded flat and government debt rose on Tuesday over rising tensions in Ukraine after Russia declared the country on the brink of civil war, though Wall Street stocks managed to end higher in a volatile session as blue chips advanced.

    Comment?